Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Sang-Eun Yoon"'
Autor:
Seong-Woo Choi, Jeong-Ja Im, Sang-Eun Yoon, Seo-Hee Kim, Jun-Hwi Cho, So-Jung Jeong, Kyung-Ae Park, Young-Sung Moon
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Tuberculosis is an infectious disease influenced by social factors rather than a simple infectious disease. In this study, we investigated the relationship between tuberculosis rates and socioeconomic status. Methods This study wa
Externí odkaz:
https://doaj.org/article/97b9994e39534102aad771ec77034cf7
Autor:
Sang Eun Yoon1, Seung-Ho Shin2, Dae Keun Nam2, Junhun Cho3, Won Seog Kim1,4, Seok Jin Kim1,4 kstwoh@skku.edu
Publikováno v:
Cancer Research & Treatment. Jul2024, Vol. 56 Issue 3, p920-935. 16p.
Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19732-19743 (2023)
Abstract Background Comprehensive molecular subtyping of diffuse large B‐cell lymphoma (DLBCL) through genetic profiling has broadened our understanding of DLBCL biology. In this study, we investigated whether DLBCL, not otherwise specified (NOS) s
Externí odkaz:
https://doaj.org/article/3438428077e949d98972b9503e3848c8
Publikováno v:
Cancer Medicine, Vol 12, Iss 15, Pp 16359-16369 (2023)
Abstract Background Although some patients with diffuse large B‐cell lymphoma (DLBCL) show a response to immunotherapy, there are still many who do not respond. This suggests that various immune checkpoints are complicatedly intertwined in the comp
Externí odkaz:
https://doaj.org/article/4ce3c97660b24e068912b1aa4cba0da8
Autor:
Sang Eun Yoon, Sujin Park, Junhun Cho, Kyung Ju Ryu, Booma Yandava, Sewon Lee, Seok Jin Kim, Won Seog Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionSoluble MHC class I-related chain A (sMICA) and B (sMICB) play a critical role tumor evolution and poor prognosis through an immune evasion mechanism. Thus, this study determines the interaction between sMICA/sMICB and the tumor immune en
Externí odkaz:
https://doaj.org/article/745c8b0762bd4e0ab1222c844cf50db1
Autor:
Jun Ho Yi, Sung-Soo Park, Chang-Ki Min, Hyeon-Seok Eom, Youngil Koh, Ja Min Byun, Sung-Soo Yoon, Jae Hoon Lee, Sung-Hoon Jung, Je-Jung Lee, Sang Eun Yoon, Kihyun Kim
Publikováno v:
HemaSphere, Vol 7, p e2906421 (2023)
Externí odkaz:
https://doaj.org/article/e97e7814e1244da7be5ff3dbaec6fc4e
Autor:
Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, Deok-Hwan Yang, Sang Eun Yoon, Gyeong-Won Lee, Jee Hyun Kong, Yong Park, Ka-Won Kang, Ho-Sup Lee, Sung Yong Oh, Ho-Jin Shin, Won Sik Lee, Yoon Seok Choi, Seong Hyun Jeong, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Sung-Nam Lim, Ho-Young Yhim, Young Rok Do, Hwan Jung Yun, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, Won Seog Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionUpfront autologous stem cell transplantation (ASCT) has been recommended for patients who are newly diagnosed with peripheral T-cell lymphoma (PTCL), and CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), an anthracycline-
Externí odkaz:
https://doaj.org/article/3ac432a63fad4f94935c09078e6069be
Autor:
Sung-Hoon Jung, Kihyun Kim, Sang Eun Yoon, Joon Ho Moon, Dajung Kim, Hyo Jung Kim, Min Kyoung Kim, Kyoung Ha Kim, Hyun Jung Lee, Ji Hyun Lee, Sung-Hyun Kim, Kawi Han Yoo, Jae Hoon Lee, Je-Jung Lee
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-6 (2022)
Abstract The International Myeloma Working Group has recently revised the diagnostic criteria for primary plasma cell leukemia (PCL) to circulating plasma cells (CPCs) ≥ 5% in a peripheral blood smear. The present study validated new criteria in pa
Externí odkaz:
https://doaj.org/article/62a2d1f52bbd4e578bd2538ffe310b67
Autor:
Jinyoung Yang, Gunho Won, Jin Yang Baek, Young Ho Lee, Haein Kim, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck, Kyo Won Lee, Jae Berm Park, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim, Min Su Yim, Kwangwook Kim, Seokhwan Hyeon, Byung Chul Kim, Yoo-kyung Lee, Jae-Hoon Ko
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe effect of tixagevimab/cilgavimab (Evusheld™; AstraZeneca, UK) should be evaluated in the context of concurrent outbreak situations.MethodsFor serologic investigation of tixagevimab/cilgavimab during the BA.5 outbreak period, sera of
Externí odkaz:
https://doaj.org/article/ebbfff69c33a4390ac032a4264dd855b
Autor:
Jin Ju Kim, Hyun-Young Kim, Zisun Choi, So yoon Hwang, Hansol Jeong, Jong Rak Choi, Sang Eun Yoon, Won Seog Kim, Sun-Hee Kim, Hee-Jin Kim, Sang-Yong Shin, Seung-Tae Lee, Seok Jin Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEpstein–Barr virus (EBV) quantitation and current imaging modalities are used for diagnosis and disease monitoring in Extranodal NK/T cell lymphoma (ENKTL) but have limitations. Thus, we explored the utility of circulating tumor DNA (ctDN
Externí odkaz:
https://doaj.org/article/513a699cb2534df2a3954bf19049b11c